BridgeMD
Compares treatment options for Elective Major Abdominal Surgery
Official title Effectiveness of Goal-Directed Fluid Therapy Guided by Cardiac Index Versus Central Venous Pressure in Major Abdominal Surgery Patients in the ICU.
ClinicalTrials.gov ID: NCT07303855
What this study is testing
- What it's testing
- This study aims to compare two different methods for guiding intravenous (IV) fluid therapy in patients during their first 6 hours in the ICU after major abdominal surgery. The goal is to determine which method leads to a more optimal and precise amount of fluid administration.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adult patients aged 18 to 65 years.
- Patients with a Body Mass Index (BMI) between 18 and 30 kg/m².
- Patients undergoing elective major abdominal surgery with a planned postoperative admission to the ICU.
- Patients with an American Society of Anesthesiologists (ASA) physical status classification of I to III.
You likely can't join if
- Patients with pre-operative cardiovascular disorders (Coronary Artery Disease, or heart failure NYHA Class III and IV).
- Patients with severe renal impairment (Chronic Kidney Disease Stage V) with or without hemodialysis and fluid restrictions.
- Non-sinus cardiac rhythm.
- Pregnancy.
- Patients with right heart failure (patients with signs of congestion and symptoms of right heart failure accompanied by evidence of reduced right...
- Patients with pulmonary hypertension (patients with echocardiographic suspicion of tricuspid regurgitation, tricuspid regurgitation velocity \> 3.4...
See the full eligibility criteria
- Adult patients aged 18 to 65 years.
- Patients with a Body Mass Index (BMI) between 18 and 30 kg/m².
- Patients undergoing elective major abdominal surgery with a planned postoperative admission to the ICU.
- Patients with an American Society of Anesthesiologists (ASA) physical status classification of I to III.
- Patients with pre-operative cardiovascular disorders (Coronary Artery Disease, or heart failure NYHA Class III and IV).
- Patients with severe renal impairment (Chronic Kidney Disease Stage V) with or without hemodialysis and fluid restrictions.
- Non-sinus cardiac rhythm.
- Pregnancy.
- Patients with right heart failure (patients with signs of congestion and symptoms of right heart failure accompanied by evidence of reduced right ventricular function, indicated by TAPSE \< 17 mm).
- Patients with pulmonary hypertension (patients with echocardiographic suspicion of tricuspid regurgitation, tricuspid regurgitation velocity \> 3.4 m/s, or mean pulmonary artery pressure \> 20 mmHg from right heart...
- Patients with Acute Respiratory Distress Syndrome (ARDS) or patients requiring specialized ventilation modes.
- Patients who refuse to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Jakarta Pusat, DKI Jakarta, Indonesia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jakarta Pusat, DKI Jakarta, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.